stars 1 stars 2 stars 3

SpectronRx is a radiopharmaceutical CDMO/CMO that is FDA and EMA-inspected. We are licensed to handle multiple pharmaceutical-grade Therapeutic and Diagnostic isotopes, including Pb-212, Lu-177, Ac-225, and I-131, for various clinical applications. We operate under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. SpectronRx also provides labeling and contract manufacturing services related to Lu-177, Ac-225, I-131, I-124, In-111, Zr-89, Cu-64 and F-18.

SpectronRx Questions

The SpectronRx annual revenue was $7.5 million in 2026.

John Zehner is the CEO of SpectronRx.

117 people are employed at SpectronRx.

Top SpectronRx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users